Annals of Epidemiology
Volume 14, Issue 1 , Pages 17-23 , January 2004

The role of gender in the long-term prognosis of patients with myocardial infarction submitted to fibrinolytic treatment

Received 31 August 2002 ,Accepted 25 March 2003.

References 

  1. Gan SC, Beaver SK, Houck PM, MacLehose RF, Lawson HW, Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med. 2000;343:8–15
  2. Marinho de Souza MF, Timerman A, Serrano CV, Santos RD, de Padua Mansur A. Trends in the risk of mortality due to cardiovascular diseases in five Brazilian geographic regions from 1979 to 1996. Arq Bras Cardiol. 2001;77:562–575
  3. Haddad N, Barbosa da Silva M. Mortality due to cardiovascular disease in women during the reproductive age (15 to 49 years), in the State of Sao Paulo, Brazil, from 1991 to 1995. Arq Bras Cardiol. 2000;75:339–342
  4. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. N Engl J Med. 1999;341:217–225
  5. Demirovic J, Blackburn H, McGovern PG, Luepker R, Sprafka JM, Gilbertson D. Sex differences in early mortality after acute myocardial infarction (the Minnesota Heart Survey). Am J Cardiol. 1995;75:1096–1101
  6. Marrugat J, Sala J, Masia R, Pavesi M, Sanz G, Valle V, et al.  Mortality differences between men and women following first myocardial infarction. JAMA. 1998;280:1405–1409
  7. Jenkins JS, Flaker GC, Nolte B, Price LA, Morris D, Kurz J, et al.  Causes of higher in-hospital mortality in women than in men after acute myocardial infarction. Am J Cardiol. 1994;73:319–322
  8. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-hospital and 1-year mortality in 1,524 women after myocardial infarction: comparison with 4,315 men. Circulation. 1991;83:484–491
  9. American Heart Association . 1997 Heart and Stroke Facts: Statistical Update. Dallas, Texas: American Heart Association; 1996;
  10. Kober L, Torp-Pedersen C, Ottesen M, Rasmussen S, Lessing M, Skagen K. Influence of gender on short- and long-term mortality after acute myocardial infarction. Am J Cardiol. 1996;77:1052–1056
  11. Yarzebski J, Col N, Pagely P, Savageau J, Gore J, Goldberg R. Gender differences and factors associated with the receipt of thrombolytic therapy in patients with acute myocardial infarction: a community-wide perspective. Am Heart J. 1996;131:43–50
  12. Kudenchuk PJ, Maynard C, Martin JS, Wirkus M, Weaver WD. Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women. Am J Cardiol. 1996;78:9–14
  13. Barakat K, Wilkinson P, Suliman A, Ranjadayalan K, Timmis A. Acute myocardial infarction in women: contribution of treatment variables to adverse outcome. Am Heart J. 2000;140:740–746
  14. Maynard C, Beshansky JR, Griffith JL, Selker HP. Influence of sex on the use of cardiac procedures in patients presenting to the emergency department: a prospective multicenter study. Circulation. 1996;94(suppl. II):II93–II98
  15. Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Speizer FE, et al.  A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA. 1991;266:521–527
  16. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group . Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311–322 [Erratum, Lancet, 343 (1994) 742.]
  17. Viscoli CM, Horwitz RI, Singer BH. Beta-blockers after acute myocardial infarction: influence of first-year clinical course on long-term effectiveness. Ann Intern Med. 1993;118:99–105
  18. Woodfield SL, Lundergan CF, Reiner JS, Thompson MA, Rohrbeck SC, Deychak Y, et al.  Gender and acute myocardial infarction: is there a different response to thrombolysis?. J Am Coll Cardiol. 1997;29:35–42
  19. Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI. Sex differences in mortality after myocardial infarction: is there evidence for an increased risk for women?. Circulation. 1995;91:1861–1871
  20. Nicolau JC, Pinto MAFV, Nogueira PR, Jacob JLB, Garzon SAC. Função ventricular esquerda na fase aguda de infartados submetidos aleatoriamente a 750.000 ou 1,5 milhão de unidades de estreptoquinase. [Left ventricular function in the acute phase of infarcted patients randomized to 750,000 or 1.5 million units of streptokinase] Arq Bras Cardiol. 1995;65:91–95
  21. RAPT. Randomized trial of Ridogrel—A combined thromboxane A2 sinthase inhibitor and thromboxane Az/prostaglandin endoperoxidase receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. Circulation. 1994;89:588–595
  22. Nicolau JC, Serrano CV, Garzon SA, Ramires JA. Prognosis of acute myocardial infarction in the thrombolytic era: medical evaluation is still valuable. Eur J Heart Fail. 2001;3:569–576
  23. Schwartz H, Leiboff RH, Bren GB, Wasserman AG, Katz RJ, Varghese PJ, et al.  Temporal evolution of the human coronary collateral circulation after myocardial infarction. J Am Coll Cardiol. 1984;4:1088–1093
  24. Nicolau JC, Pinto MAF, Nogueira PR, Lorga AM, Jacob JLB, Garzon SAC. Preditores da sobrevida intra-hospitalar em pacientes infartados submetidos à terapêutica fibrinolı́tica. [Predictors of in-hospital survival among infarcted patients submitted to fibronolytic therapy] Arq Bras Cardiol. 1993;61:143–148
  25. Nicolau JC, Garzon SAC, Pinto MAFV, Nogueira PR, Lorga AM, Greco OT. Acute myocardial infarction treated with intravenous streptokinase: 6-year follow-up. Int J Cardiol. 1993;38:253–262
  26. Gruppo Italiano per lo della Sterptochinasi nell' Infarto Miocardico (GISSI) . Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;i:397–402
  27. Herman B, Greiser E, Pohlabeln H. A sex difference in short-term survival after initial acute myocardial infarction: the MONICA-Bremen Acute Myocardial Infarction Register, 1985–1990. Eur Heart J. 1997;18:963–970
  28. Weaver W, White H, Wilcox R, Aylward P, Morris D, Guerci A, et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. JAMA. 1996;275:777–782
  29. Malacrida R, Genoni M, Maggioni AP, Spataro V, Parish S, Palmer A, et al.  for the third International Study of Infarct Survival collaborative group   A comparison of the early outcome of acute myocardial infarction in women and men. N Engl J Med. 1998;338:8–14
  30. Tunstall-Pedoe H, Morrison C, Woodward M, Fitzpatrick B, Watt G. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Circulation. 1996;93:1981–1992
  31. Rieves D, Wright G, Gupta G, Shacter E. Clinical trial (GUSTO-1) and INJECT) evidence of earlier death for men than women after acute myocardial infarction. Am J Cardiol. 2000;147–153
  32. MacIntyre K, Stewart S, Capewell S, Chalmers JWT, Pell JP, Boyd J, et al.  Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction. J Am Coll Cardiol. 2001;38:729–735
  33. Heer T, Schiele R, Schneider S, Gitt AK, Wienbergen H, Gottwik M, et al.  Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA Registry). Am J Cardiol. 2002;89:511–517
  34. Chandra NC, Ziegelstein RC, Rogers WJ, Tiefenbrunn AJ, Gore JM, French WJ, et al.  Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction - I. Arch Intern Med. 1998;158:981–988
  35. Antoniucci D, Valenti R, Moschi G, Migliorini A, Trapani M, Santoro GM, et al.  Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol. 2001;87:289–293
  36. Herlitz J, Bång A, Hartford M, Karlson BW. Influence of gender on survival, mode of death, reinfarction, use of medication, and aspects of well being during a period of five years after onset of acute myocardial infarction. Clin Cardiol. 1996;19:555–561
  37. Galatius-Jensen S, Launbjerg J, Mortensen S, Hansen JF. Sex related differences in short and long term prognosis after acute myocardial infarction: 10 year follow up of 3073 patients in database of first Danish verapamil infarction trial. BMJ. 1996;313:137–140
  38. Schreiner PJ, Niemelä M, Miettinen H, Mähönen M, Ketonen M, Immonen-Räiha P, et al.  Gender differences in recurrent coronary events. The FINMONINCA MI register. Eur Heart J. 2001;22:762–768
  39. Harpaz D. Ethnic differences in mortality of male and female patients surviving acute myocardial infarction: long-term follow-up of 5,700 patients. The Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group. Eur J Epidemiol. 1997;13:745–754
  40. White HD, Barbash GI, Modan M, Simes J, Diaz R, Hampton JR, et al.  After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The investigators of the international tissue plasminogen activator/streptokinase mortality study. Circulation. 1993;88:2097–2103
  41. Rieves D, Wright G, Gupta G, Shacter E. Clinical trial (GUSTO-1 and INJECT) evidence of earlier death for men than women after acute myocardial infarction. Am J Cardiol. 2000;147–153

PII: S1047-2797(03)00076-0

doi: 10.1016/S1047-2797(03)00076-0

Annals of Epidemiology
Volume 14, Issue 1 , Pages 17-23 , January 2004

Article Tools

* Image Usage & Resolution